Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Focal Glomerulosclerosis”

116 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 116 results

Testing effectiveness (Phase 2)Study completedNCT04009668
What this trial is testing

Tumor Necrosis Factor Inhibition in Focal Segmental Glomerulosclerosis and Treatment Resistant Minimal Change Disease

Who this might be right for
FSGSMCDFocal Segmental Glomerulosclerosis+1 more
University of Michigan 7
Not applicableUnknownNCT00956059
What this trial is testing

Therapeutic Effect of Low-dose Prednisone Combined With MMF and FK506 in Focal Segmental Glomerulosclerosis

Who this might be right for
Focal Segmental Glomerulosclerosis
Xi'an Jiaotong University 40
Early research (Phase 1)Study completedNCT00353535
What this trial is testing

Total Lymphoid Irradiation (TLI) to Prevent Focal Segmental Glomerulosclerosis (FSGS)Recurrence in the Renal Graft

Who this might be right for
Glomerulosclerosis, Focal
University of Sao Paulo 10
Testing effectiveness (Phase 2)Study completedNCT04983888
What this trial is testing

Obinutuzumab in Primary FSGS

Who this might be right for
Primary Focal Segmental Glomerulosclerosis
Mayo Clinic 20
Testing effectiveness (Phase 2)Looking for participantsNCT06664814
What this trial is testing

An Open-Label Phase 2 Study of N-Acetyl-D-Mannosamine (ManNAc) in Subjects With Podocyte Diseases

Who this might be right for
Focal Segmental Glomerulosclerosis
National Human Genome Research Institute (NHGRI) 30
Early research (Phase 1)Ended earlyNCT00782561
What this trial is testing

Safety and Pharmacokinetics of FG-3019 in Adolescents and Adults With Focal Segmental Glomerulosclerosis (FSGS)

Who this might be right for
Focal Segmental Glomerulosclerosis
Kyntra Bio 2
Post-approval studies (Phase 4)Study completedNCT02585804
What this trial is testing

Treating to Reduce Albuminuria and Normalize Hemodynamic Function in Focal ScLerosis With dApagliflozin Trial Effects

Who this might be right for
Focal Segmental Glomerulosclerosis
University Health Network, Toronto 10
Testing effectiveness (Phase 2)Study completedNCT02000440
What this trial is testing

A Phase II, Repeat Dose, Proof of Mechanism Study of Losmapimod to Reduce Proteinuria in Patients With Focal Segmental Glomerulosclerosis (FSGS)

Who this might be right for
Glomerulosclerosis, Focal Segmental
GlaxoSmithKline 17
Post-approval studies (Phase 4)Study completedNCT01129284
What this trial is testing

Treatment of Resistant Nephrotic Syndrome With ACTH Gel (ACTHAR)

Who this might be right for
Treatment Resistant Nephrotic Syndrome
Columbia University 15
Not applicableStudy completedNCT00001393
What this trial is testing

Genetic Markers for Focal Segmental Glomerulosclerosis

Who this might be right for
Focal Segmental GlomerulosclerosisHIV-Associated Focal Segmental Glomerulosclerosis
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) 616
Not applicableStudy completedNCT01370200
What this trial is testing

Regional Citrate Anticoagulation in Plasma Exchange Treatment

Who this might be right for
Focal Segmental GlomerulosclerosisGuillain-Barre Syndrome
University Medical Centre Ljubljana 140
Not applicableStudy completedNCT01835639
What this trial is testing

Vitamin D Supplementation in Glomerular Disease

Who this might be right for
Glomerular Disease
Children's Hospital of Philadelphia 32
Testing effectiveness (Phase 2)WithdrawnNCT05599815
What this trial is testing

Part 1 - A Clinical Trial in Patients With Frequently Relapsing and Steroid-Dependent Nephrotic Syndrome

Who this might be right for
Nephrotic Syndrome
Aldeyra Therapeutics, Inc.
Early research (Phase 1)Looking for participantsNCT05942625
What this trial is testing

A First in Human Study to Evaluate Safety, Tolerability, Pharmacology of HS-10390 in Healthy Subjects

Who this might be right for
IgA NephropathyFocal Segmental Glomerulosclerosis
Hansoh BioMedical R&D Company 84
Not applicableLooking for participantsNCT07010250
What this trial is testing

Epithelial Dysmetabolism and Renal Fibrosis in ANCA Vasculitis

Who this might be right for
ANCA Associated VasculitisExtramembranous GlomerulopathyNephrotic Syndrome, Minimal Change+4 more
Assistance Publique - Hôpitaux de Paris 146
Not applicableLooking for participantsNCT01094327
What this trial is testing

Proteinuria in Pre and Post Transplant

Who this might be right for
Proteinuria
University of Miami 100
Large-scale testing (Phase 3)Looking for participantsNCT05183646
What this trial is testing

The Efficacy and Safety of DMX-200 in Patients With FSGS Who Are Receiving an ARB

Who this might be right for
FSGS
Dimerix Bioscience Pty Ltd 286
Large-scale testing (Phase 3)Looking for participantsNCT07220083
What this trial is testing

Find Out if BI 764198 Helps Adults and Adolescents With a Kidney Condition Called Focal Segmental Glomerulosclerosis (FSGS)

Who this might be right for
Focal Segmental Glomerulosclerosis
Boehringer Ingelheim 286
Not applicableLooking for participantsNCT06162546
What this trial is testing

ARREST-NEPHROSIS - Austrian Resistant Nephrotic Syndrome Treatment Response Registry and Biobank

Who this might be right for
Focal Segmental GlomerulosclerosisProteinuriaNephrotic Syndrome+1 more
Christoph Aufricht 100
Early research (Phase 1)Study completedNCT05955872
What this trial is testing

A Study Evaluating the Relative Bioavailability and Food Effect of a Tablet Formulation of VX-147

Who this might be right for
Focal Segmental Glomerulosclerosis (FSGS)
Vertex Pharmaceuticals Incorporated 21
Next Page